Chengfei Yang

Xinqiao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Alisol B 23-acetate alleviates lipopolysaccharide-induced acute lung injury by targeting ANXA1 to modulate the ANXA1/FPR2-mediated MAPK/NF-κB signaling axis.

Alisol B 23-acetate alleviates lipopolysaccharide-induced acute lung injury by targeting ANXA1 to modulate the ANXA1/FPR2-mediated MAPK/NF-κB signaling axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 10, 2026

Biorthogonal click-immobilized probiotic membrane vesicles in a dynamic hydrogel for accelerated and scar-minimized wound healing.

Biorthogonal click-immobilized probiotic membrane vesicles in a dynamic hydrogel for accelerated and scar-minimized wound healing.

Journal: Materials today. Bio

Published: January 13, 2026

Single-nucleus sequencing dissects the malignant change of early lung adenocarcinoma: SMAD3 suppresses antitumor T cell immunity via ICAM1.

Single-nucleus sequencing dissects the malignant change of early lung adenocarcinoma: SMAD3 suppresses antitumor T cell immunity via ICAM1.

Journal: NPJ precision oncology

Published: December 12, 2025

Protocadherin gamma subfamily A, 3 inhibits the proliferation and metastasis of lung adenocarcinoma by inhibiting transforming growth factor β signaling pathway.

Protocadherin gamma subfamily A, 3 inhibits the proliferation and metastasis of lung adenocarcinoma by inhibiting transforming growth factor β signaling pathway.

Journal: Respiratory research

Published: November 14, 2025

Analysis of clinicopathological characteristics in postoperative molecular residual disease-positive stage I non-small cell lung cancer patients.

Analysis of clinicopathological characteristics in postoperative molecular residual disease-positive stage I non-small cell lung cancer patients.

Journal: Journal of thoracic disease

Published: September 26, 2025

Recent advances and challenges of cellular immunotherapies in lung cancer treatment.

Recent advances and challenges of cellular immunotherapies in lung cancer treatment.

Journal: Experimental hematology & oncology

Published: October 09, 2024

Chemokine receptor 7 contributes to T- and B-cell filtering in ageing bladder, cystitis and bladder cancer.

Chemokine receptor 7 contributes to T- and B-cell filtering in ageing bladder, cystitis and bladder cancer.

Journal: Immunity & ageing : I & A

Published: February 27, 2024

Inhibition of integrin receptors reduces extracellular matrix levels, ameliorating benign prostate hyperplasia.

Inhibition of integrin receptors reduces extracellular matrix levels, ameliorating benign prostate hyperplasia.

Journal: International journal of biological macromolecules

Published: May 11, 2023

Ginsenoside Rg1 improves anti-tumor efficacy of adoptive cell therapy by enhancing T cell effector functions.

Ginsenoside Rg1 improves anti-tumor efficacy of adoptive cell therapy by enhancing T cell effector functions.

Journal: Blood science (Baltimore, Md.)

Published: January 14, 2023

Single-cell profiling reveals various types of interstitial cells in the bladder.

Single-cell profiling reveals various types of interstitial cells in the bladder.

Journal: Cell proliferation

Published: October 21, 2022

Decreased autophagic activity of detrusor cells is involved in the inflammatory response of interstitial cystitis/bladder pain syndrome.

Decreased autophagic activity of detrusor cells is involved in the inflammatory response of interstitial cystitis/bladder pain syndrome.

Journal: International urogynecology journal

Published: January 06, 2022

Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF-κB Pathways.

Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF-κB Pathways.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: August 05, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026